1h Free Analyst Time
The tyrosine kinase inhibitors market is forecasted to grow by USD 21.8 billion during 2024-2029, accelerating at a CAGR of 7.7% during the forecast period. The report on the tyrosine kinase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity of tyrosine kinase inhibitors, rising availability of patient assistance programs, and increasing prevalence of cancer worldwide.
The tyrosine kinase inhibitors market is segmented as below:
By Product
- RTKIs
- nRTKIs
By Distribution Channel
- Offline
- Online
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the tyrosine kinase inhibitors market covers the following areas:
- Tyrosine Kinase Inhibitors Market sizing
- Tyrosine Kinase Inhibitors Market forecast
- Tyrosine Kinase Inhibitors Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Distribution Channel
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global tyrosine kinase inhibitors market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Danaher Corp., Eisai Co. Ltd., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Merck KGaA, Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Rigel Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and Tokyo Chemical Industry Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic alliances among market vendors."
According to the report, one of the major drivers for this market is the high target affinity and specificity of tyrosine kinase inhibitors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Danaher Corp.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- Exelixis Inc.
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Puma Biotechnology Inc.
- Rigel Pharmaceuticals Inc.
- Takeda Pharmaceutical Co. Ltd.
- Tokyo Chemical Industry Co. Ltd.
